Business
The Starpharma (ASX:SPL) share price is 35% below its 52-week high
Shares in mid-cap ASX biopharmaceuticals company Starpharma Holdings Limited (ASX: SPL) have endured a volatile start to 2021. After surging to an all-time high of $2.52 by mid-February, the company’s shares have now plunged more than 35% to just $1.62 as at the time of writing.
While…
Continue Reading
-
Noosa News17 hours agoGaming policy on council’s agenda
-
Business18 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
Noosa News14 hours agoJetstar flights resume across Australia after Airbus A320 software issue identified
-
Business17 hours ago1 ASX dividend stock down 28% I’d buy right now